万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>期刊大全 >>SCI/SCIE期刊 >>医药卫生>>外科学

Atherosclerosis(研究方向:外周血管病) (官网投稿)

简介
Atherosclerosis(月刊),创刊于1970年,出版国家为美国。Atherosclerosis从所有来源收集关于动脉粥样硬化,其风险因素和临床表现的研究的论文。涵盖基本和平移,临床和人口研究接近动脉和血管生物学和疾病,以及它们的风险因素,包括:脂质和脂蛋白的代谢,糖尿病的紊乱和高血压,血栓形成,和炎症。
本刊为:SCI期刊(2015-2016), SCIE期刊(2015-2016), 外文期刊,
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊官网:

https://www.journals.elsevier.com/atherosclerosis/

3、期刊投稿:

https://ees.elsevier.com/ath/default.asp?acw=5282-308

4、官网邮箱:arnold.voneckardstein@usz.ch

5、信息说明:本刊信息来源于网络,包括 SCI 收录核心期刊,增补期刊,期刊收录数据每年进行更新。本站是公益性网站,为网友投稿提供免费服务,由于受相关约束,我们不能提供相关期刊的影响因子、JCR期刊分区等数据供大家参考,造成不便,敬请谅解。

2017314日星期二

                        

 

Instructions to Authors

 

Atherosclerosis is a fully electronic journal, all manuscripts are to be submitted via the internet. To submit your paper online, click on the link http://ees.elsevier.com/ath/.

 

Types of paper

 

Types of papers that can be submitted for consideration by the Editorial Board include:

 

a) Original Research Papers are divided into three categories:

 

Basic Research Papers reporting results of original research or investigation using in vitro cell culture or animal models.

Clinical and Population Research Papers reporting results of investigation in human subjects including observational, interventional and genetic studies. Meta-analyses and genetic association studies will also be published under this category. For publication of clinical trials, genetic association studies and meta-analyses, please consult the dedicated Special Guidelines below.

Translational Research Papers reporting results of research from both bench-to-bedside and bedside-to-bench.

The following word limits apply: abstract 250 words, main text 4000 words (including legends to figures and tables), 5 figures and/or tables in total (authors are encouraged to include additional figures and tables as Supplementary Material) and a maximum of 50 references. Flexibility on word count may be offered after discussion with the Editor.

 

Rapid Communications. Authors may choose to submit their Original Research Paper as Rapid Communication. These papers should provide a brief but complete account of important new observations that merit urgent publication. Authors should clearly state in the covering letter why the paper merits urgent publication. The Editor-in-Chief will normally reach a decision on these papers within three weeks. Papers requiring revision will not be considered as Rapid Communications. The following word limits apply: abstract 150 words, main text 3000 words (including legends to figures and tables), 3 figures and/or tables in total, and a maximum of 25 references.

 

b) Review Articles. Atherosclerosis publishes review articles on topics of great interest or controversy in basic, translational, clinical or population research. Authors who have not been priorly invited to submit a Review by the Editors of Atherosclerosis are advised to write a letter of interest to the Editorial Office, accompanied by an abstract. Based on this, the Editors will encourage or discourage submission. In all cases, Review Articles undergo peer review. The following word limits apply: abstract 250 words, main text 5000 words, 6 figures and/or tables in total, and a maximum of 100 references. Authors are encouraged to include a "mechanism/overview" figure and one or more bullet point boxes highlighting the main key-points.

 

c) Editorials and Correspondence. Editorials will be commissioned by the Editors, who will approach a suitably qualified author to write a commentary on a recently accepted Original Research Paper of particular interest. Editorials should not exceed 1500 words and 20 references. 1 figure or table is allowed.

 

If you have specific issues that you wish to raise concerning work published in Atherosclerosis, please submit your opinions as a Correspondence. Correspondence articles should not exceed 1000 words (including references), 10 references and 2 figures and/or tables. The inclusion of novel data will increase the chance of acceptance. The Author(s) of the commented manuscript will have the opportunity to respond to the comments in the same issue of the Journal. Please submit Correspondence to the Editor-in-Chief Arnold von Eckardstein.

 

In each issue, the following manuscripts will be made available free of charges online:

 

Up to 4 original articles selected by the Editor-in-Chief

Invited reviews

Editorials

Contact information

 

Editor-in-Chief

Professor Arnold von Eckardstein

Institute of Clinical Chemistry

University Hospital and University of Zurich

Rämistrasse 100, Zurich

CH-8091

Switzerland

Fax: +41442554590

E-mail: arnold.voneckardstein@usz.ch

 

编辑委员会

 

主编

A. von Eckardstein

Zürich, 瑞士

Immediate Past Editor

S. Humphries

英国伦敦

Supplements Editor

A.L. Catapano

Milan, Italy

Co-Editors

J. Borén

Göteborg, Sweden

A.L. Catapano

Milan, Italy

G. Dallinga-Thie

Amsterdam, Netherlands

P. Raggi

Edmonton, Alberta, Canada

G.F. Watts

Perth, Western Australia, Australia

Associate Editors

S. Agewall

Oslo, Norway

J. Armitage

Oxford, UK

R. Asmis

San Antonio, Texas, USA

D. Chan

Perth, Western Australia, Australia

Y.S. Chatzizisis

Boston, Massachusetts, USA

E. de Muinck

Linköping, Sweden

E. Emanuele

Pavia, Italy

G.P. Fadini

Padova, Italy

C. Falcone

Pavia, Italy

M. Federici

Rome, Italy

C. Fernández-Hernando

New Haven, Connecticut, USA

J. Heeren

Hamburg, Germany

R. Hegele

London, Ontario, Canada

K. Ikewaki

Saitama, Japan

M.L. Koschinsky

London, Ontario, Canada

F. Kronenberg

Innsbruck, Austria

E. Lutgens

Amsterdam, Netherlands

Z. Mallat

Cambridge, UK

L. Martinez

Toulouse, France

S. Mohlenkamp

Moers, Germany

Y. Momiyama

Tokyo, Japan

S.J. Nicholls

Adelaide, South Australia, Australia

D. Norata

Milan, Italy

K. Öörni

Helsinki, Finland

A. Rigotti

Santiago, Chile

K. Saku

Fukuoka, Japan

R.D. Santos

São Paulo, Brazil

A. Schmidt-Trucksäss

Basel, Switzerland

A. Sposito

Campinas, Brazil

M. van Eck

Leiden, Netherlands

M.M.J. van Greevenbroek

Maastricht, Netherlands

P. Welsh

Glasgow, Scotland, UK

L. Yvan-Charvet

Nice, France

Statistics Editor

G. Corrao

Milan, Italy

M. Tanck

Amsterdam, Netherlands

Editorial Board Members

H. Adachi

Kurume, Japan

W. Ageno

Varese, Italy

P. Alakija

Edmonton, Alberta, Canada

A.V. Andjelkovic

Ann Arbor, Michigan, USA

B. Arsenault

Québec, Quebec, Canada

J. Auer

Braunau, Austria

M. Averna

Palermo, Italy

L. Badimon

Barcelona, Spain

K.R. Bainey

Edmonton, Alberta, Canada

M. Banach

Lodz, Poland

H. Barrett

Perth, Western Australia, Australia

P.J. Barter

Sydney, New South Wales, Australia

A. Bellasi

Como, Italy

L. Berglund

Sacramento, California, USA

M. Berndt

Perth, Australia

E. Biessen

Aachen, Germany

C. Binder

Vienna, Austria

M. Boehm

Bethesda, Maryland, USA

M.J. Bown

Leicester, UK

H. Bujo

Sakura, Japan

J.R. Burnett

Crawley, Western Australia, Australia

G. Camejo

Molndal, Sweden

L.S.F. Carvalho

São Paulo, Brazil

M. Castro Cabezas

Rotterdam, Netherlands

M.J. Chapman

Paris, France

B. Chow

Ottawa, Ontario, Canada

A. Cignarella

Padova, Italy

E. de Groot

Amsterdam, Netherlands

L. De Nicola

Naples, Italy

J-P. Després

Quebec City, Quebec, Canada

M. Di Nisio

Chieti Scalo, Italy

M.S. Elisaf

Loannina, Greece

E. Ercan

Ìzmir, Turkey

Z.A. Fayad

New YorK, New York, USA

G.A. Francis

Vancouver, British Columbia, Canada

R. Frikke-Schmidt

København, Denmark

S.J. George

Bristol, England, UK

J. Golledge

Townsville, Queensland, Australia

I.M. Graham

Dublin, Ireland

M. Hagger

Perth, Western Australia, Australia

M. Harada-Shiba

Osaka, Japan

A. Hirayama

Itabashi-ku, Japan

E. Hurt-Camejo

Göteborg, Sweden

R. Huxley

Perth, Australia

N. Jahroudi

Edmonton, Alberta, Canada

M.S. Jauhiainen

Helsinki, Finland

L. Jiang

China

S. Kasayama

Osaka, Japan

B. Kingwell

Melbourne, Victoria, Australia

W. Koenig

Ulm, Germany

Y. Kokubo

Osaka, Japan

K. Kostner

Queensland, Australia

D. Kratky

Graz, Austria

L. Kritharides

Sydney, New South Wales, Australia

J. A. Kuivenhoven

Groningen, Netherlands

C. Lamina

Innsbruck, Austria

U. Laufs

Homburg, Germany

J.A. Leipsic

Vancouver, British Columbia, Canada

F. Mach

Geneva, Switzerland

M.I. Mackness

Manchester, UK

J. Mamo

Perth, Australia

L. Masana

Reus, Spain

M. McMurtry

Edmonton, Alberta, Canada

P. Meikle

Melbourne, Victoria, Australia

T.A. Mori

Perth, Western Australia, Australia

E.H. Moriguchi

Porto Alegre, Brazil

A. Moschetta

Santa Maria Imbaro (CH), Italy

E.K. Moses

Perth, Western Australia, Australia

A. Murphy

Melbourne, Victoria, Australia

Y. Nakamura

Shiga, Japan

E.P. Navarese

Milan, Italy

H.M. Nawawi

Milan, Italy

D. Neely

Newcastle-upon-Tyne, England, UK

P.J. Nestel

Melbourne, Victoria, Australia

A.C. Newby

Bristol, England, UK

L.B. Nielsen

København, Denmark

J.-R. Nofer

Münster, Germany

R. Padwal

Edmonton, Alberta, Canada

P. Parini

Stockholm, Sweden

G. Pasterkamp

Utrecht, Netherlands

F.J. Raal

Johannesburg, South Africa

Z. Reiner

Zagreb, Croatia

A.T. Remaley

Bethesda, Maryland, USA

P.C.N. Rensen

Leiden, Netherlands

N. Riksen

Nijmegen, Netherlands

S. Romeo

Gothenburg, Sweden

P. Rubba

Naples, Italy

L.L. Rudel

Winston-Salem, North Carolina, USA

C. G. Santos-Gallego

New York, USA

C. Schultz

Perth, Western Australia, Australia

C.M. Sergi

Edmonton, Alberta, Canada

E.J.G. Sijbrands

Rotterdam, Netherlands

H. Soran

Manchester, England, UK

D. Sviridov

Melbourne, Victoria, Australia

L. Tokgözoglu

Ankara Province, Turkey

G.M. Trovato

Catania, Italy

S. Tsimikas

La Jolla, California, USA

J.P. van Buul

Amsterdam, Netherlands

B.-J. van den Born

Amsterdam, Netherlands

M. Vrablík

Prague, Czech Republic

P. Weinberg

London, England, UK

R. Welsh

Edmonton, Alberta, Canada

O. Wiklund

Goteborg, Sweden

S. Yamashita

Osaka, Japan

N. Zelcer

Amsterdam, Netherlands

A. Zernecke

Würzburg, Germany

Managing Editor

S. Negrini

Zurich, Switzerland


投稿问答最小化  关闭